267 related articles for article (PubMed ID: 24632413)
1. Coexistence of gastrointestinal stromal tumours (GIST) and malignant neoplasms of different origin: prognostic implications.
Vassos N; Agaimy A; Hohenberger W; Croner RS
Int J Surg; 2014; 12(5):371-7. PubMed ID: 24632413
[TBL] [Abstract][Full Text] [Related]
2. [Gastrointestinal stromal tumour: our experience].
Versaci A; Macrì A; Ieni A; Terranova M; Leonello G; Saladino E; Speciale G; Famulari C
Chir Ital; 2009; 61(2):161-9. PubMed ID: 19536989
[TBL] [Abstract][Full Text] [Related]
3. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological features and management of gastrointestinal stromal tumors complicated with synchronous other alimentary malignant tumor].
Zhuang C; Wang M; Qiu WQ; Xu J; Shen ZY; Cao H
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):234-8. PubMed ID: 23536342
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumors (GIST) related emergencies.
Sorour MA; Kassem MI; Ghazal Ael-H; El-Riwini MT; Abu Nasr A
Int J Surg; 2014; 12(4):269-80. PubMed ID: 24530605
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract][Full Text] [Related]
8. Synchronous gastrointestinal stromal tumors (GIST) and other primary cancers: case series of a single institution experience.
Ferreira SS; Werutsky G; Toneto MG; Alves JM; Piantá CD; Breunig RC; Brondani da Rocha A; Grivicich I; Garicochea B
Int J Surg; 2010; 8(4):314-7. PubMed ID: 20380900
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal stromal tumours in patients with other-type cancer: a mere coincidence or an etiological association? A study of 97 GIST cases.
Agaimy A; Wuensch PH
Z Gastroenterol; 2005 Sep; 43(9):1025-30. PubMed ID: 16142610
[TBL] [Abstract][Full Text] [Related]
10. [Dual tumours in the GI tract: synchronous and metachronous stromal (GIST) and epithelial/neuroendocrine neoplasms].
Kövér E; Faluhelyi Z; Bogner B; Kalmár K; Horváth G; Tornóczky T
Magy Onkol; 2004; 48(4):315-21. PubMed ID: 15655577
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
Wu TJ; Lee LY; Yeh CN; Wu PY; Chao TC; Hwang TL; Jan YY; Chen MF
BMC Gastroenterol; 2006 Oct; 6():29. PubMed ID: 17062131
[TBL] [Abstract][Full Text] [Related]
12. Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis.
Quattrone A; Dewaele B; Wozniak A; Bauters M; Vanspauwen V; Floris G; Schöffski P; Chibon F; Coindre JM; Sciot R; Debiec-Rychter M
J Pathol; 2012 Dec; 228(4):565-74. PubMed ID: 22786615
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of clinicopathology and prognosis in 181 patients with gastrointestinal stromal tumors].
Zhang Y; Cao H; Wang M; Shen DP; Shen ZY; Ni XZ; Wu ZY; Shen YY; Liu Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):150-4. PubMed ID: 19296250
[TBL] [Abstract][Full Text] [Related]
14. An audit of surgical management of gastrointestinal stromal tumours (GIST).
Bucher P; Egger JF; Gervaz P; Ris F; Weintraub D; Villiger P; Buhler LH; Morel P
Eur J Surg Oncol; 2006 Apr; 32(3):310-4. PubMed ID: 16414236
[TBL] [Abstract][Full Text] [Related]
15. Synchronous gastrointestinal cancer and gastrointestinal stromal tumors: a single-institution experience.
Du J; Shen N; He HS; Fu XL; Wang JZ; Mao CZ
World J Surg Oncol; 2016 Apr; 14():130. PubMed ID: 27129592
[TBL] [Abstract][Full Text] [Related]
16. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up outcome of imatinib mesylate treatment for recurrent and unresectable gastrointestinal stromal tumors.
Saito S; Nakata K; Kajiura S; Ando T; Hosokawa A; Sugiyama T
Digestion; 2013; 87(1):47-52. PubMed ID: 23343969
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal stromal tumour: spiral computed tomography features and pathologic correlation.
Da Ronch T; Modesto A; Bazzocchi M
Radiol Med; 2006 Aug; 111(5):661-73. PubMed ID: 16791465
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous occurrence of synchronous and metachronous tumors with gastrointestinal stromal tumors.
Adim SB; Filiz G; Kanat O; Yerci O
Bratisl Lek Listy; 2011; 112(11):623-5. PubMed ID: 22180988
[TBL] [Abstract][Full Text] [Related]
20. [Gastrointestinal stromal tumors].
Ignjatović M
Vojnosanit Pregl; 2002; 59(2):183-202. PubMed ID: 12053473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
